PierianDx

The company offers products and services for analyzing, interpreting, and reporting clinical next-generation sequencing data with a focus on cancer.

The company also said it has been awarded a research sequencing grant from Illumina Accelerator.

The companies will integrate PierianDx's informatics solution with two of Illumina's NGS cancer research panels and as well as future IVD products.

Allscripts subsidiary 2bPrecise will work with startup PierianDx to combine NGS and clinical data as they seek to advance precision care for cancer patients.

Malaysia-based ScienceVision has agreed to commercialize and distribute the PierianDx Clinical Genomics Workspace platform in Southeast Asian countries.

The firms will work to accelerate the adoption of PierianDx's genomics platform for translating data into patient-specific diagnoses and treatments.

The companies will join their respective technologies into a precision oncology testing and analysis offering.

WUSTL bioinformatics spinout PierianDx disclosed in an SEC filing that it has raised slightly more than $3 million of a $5 million offering.